The gel state of the vitreous and ascorbate-dependent oxygen consumption

Archives of Ophthalmology

Volumn 127, Issue 4, 2009, Pages 475-482

  Shui, Ying Bo ^a   Holekamp, Nancy M ^a,d   Kramer, Benjamin C ^a   Crowley, Jan R ^b   Wilkins, Mark A ^a   Chu, Fred ^a   Malone, Paula E ^a   Mangers, Shayna J ^a   Hou, Joshua H ^a   Siegfried, Carla J ^a   Beebe, David C ^a,c,e  

^a Department of Ophthalmology and Visual Sciences ^*  (United States)

^b Division of Endocrinology   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BARNES RETINA INSTITUTE   (United States)

^e WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBATE OXIDASE; ASCORBIC ACID; DEFEROXAMINE; EDETIC ACID;

ARTICLE; CATARACT; HUMAN; LENS; LIQUEFACTION; MASS FRAGMENTOGRAPHY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RETINA SURGERY; SPECTROPHOTOMETRY; VITRECTOMY; VITREOUS BODY;

ASCORBATE OXIDASE; ASCORBIC ACID; CATARACT; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GELS; HUMANS; OXYGEN; OXYGEN CONSUMPTION; RETINAL DISEASES; VITRECTOMY; VITREOUS BODY;

EID: 65249091452     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2008.621     Document Type: Article

References (51)

1. Murray CJL, Lopez AD. Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard School of Public Health; 1996.
2. Salm M, Belsky D, Sloan FA. Trends in cost of major eye diseases to Medicare, 1991 to 2000. Am J Ophthalmol. 2006;142(6):976-982.
3. SpectorA. Oxidative stress-induced cataract: mechanism of action. FASEBJ. 1995; 9(12):1173-1182.
4. Truscott RJ, Augusteyn RC. Oxidative changes in human lens proteins during senile nuclear cataract formation. Biochim Biophys Acta. 1977;492(1):43-52.
5. Holekamp NM, Shui Y-B, Beebe D. Lower intraocular oxygen tension in diabetic patients: possible contribution to decreased incidence of nuclearsclerotic cataract. Am J Ophthalmol. 2006;141(6):1027-1032.
6. Helbig H, Hinz JP, Kellner U, Foerster MH. Oxygen in the anterior chamber of the human eye. Ger J Ophthalmol. 1993;2(3):161-164.
7. Holekamp NM, Shui YB, Beebe DC. Vitrectomy surgery increases oxygen exposure to the lens: a possible mechanism for nuclear cataract formation. Am J Ophthalmol. 2005;139(2):302-310.
8. Palmquist BM, Philipson B, Barr PO. Nuclear cataract and myopia during hyperbaric oxygen therapy. Br J Ophthalmol. 1984;68(2):113-117.
9. Lyne AJ. Ocular effects of hyperbaric oxygen. Trans Ophthalmol Soc UK. 1978; 98(1):66-68.
10. Fischer BH, Marks M, Reich T. Hyperbaric-oxygen treatment of multiple sclerosis: a randomized, placebo-controlled, double-blind study. N Engl J Med. 1983; 308(4):181-186.
11. Fledelius HC, Jansen EC, Thorn J. Refractive change during hyperbaric oxygen therapy: a clinical trial including ultrasound oculometry. ActaOphthalmolScand. 2002;80(2):188-190.
12. Novak MA, Rice TA, Michels RG, AuerC.The crystalline lens aftervitrectomy for diabetic retinopathy. Ophthalmology. 1984;91(12):1480-1484.
13. Melberg NS, Thomas MA. Nuclearsclerotic cataract aftervitrectomy in patients youngerthan 50 years of age. Ophthalmology. 1995;102(10):1466- 1471.
14. de Bustros S, Thompson JT, Michels RG, Enger C, Rice TA, Glaser BM. Nuclear sclerosis aftervitrectomy for idiopathic epiretinal membranes. Am J Ophthalmol. 1988;105(2):160-164.
15. Thompson JT, Glaser BM, Sjaarda RN, Murphy RP. Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes. Am J Ophthalmol. 1995;119(1):48-54.
16. Wilson CA, Berkowitz BA, McCuen BW II, Charles HC. Measurement of prereti-nal oxygen tension in the vitrectomized human eye using fluorine-19 magnetic resonance spectroscopy. Arch Ophthalmol. 1992;110(8):1098-1100.
17. Berkowitz BA, Kowluru RA, Frank RN, Kern TS, Hohman TC, Prakash M. Subnormal retinal oxygenation response precedes diabetic-like retinopathy. Invest Ophthalmol Vis Sci. 1999;40(9):2100-2105.
18. Linsenmeier RA, Goldstick TK, Blum RS, Enroth-Cugell C. Estimation of retinal oxygen transients from measurements made in the vitreous humor. Exp Eye Res. 1981;32(4):369-379.
19. Alder VA, Niemeyer G, Cringle SJ, Brown MJ. Vitreal oxygen tension gradients in the isolated perfused cat eye. Curr Eye Res. 1986;5(4):249-256.
20. Cringle SJ, Yu D-Y. Intraretinal oxygenation and oxygen consumption in the rabbit during systemic hyperoxia. Invest Ophthalmol Vis Sci. 2004;45(9):3223-3228.
21. McNulty R, Wang H, Mathias RT, Ortwerth BJ, Truscott RJW, Bassnett S. Regulation of tissue oxygen levels in the mammalian lens. J Physiol. 2004;559(pt 3): 883-898.
22. Barbazetto IA, Liang J, Chang S, Zheng L, SpectorA, Dillon JP. Oxygen tension in the rabbit lens and vitreous before and after vitrectomy. Exp Eye Res. 2004; 78(5):917-924.
23. 2 gradients and countercurrent exchange in the cat vitreous humor near retinal arterioles and venules. Micro-vascRes. 1993;45(2):134-148.
24. Harocopos GJ, Shui Y-B, McKinnon M, Holekamp NM, Gordon MO, Beebe DC. Importance of vitreous liquefaction in age-related cataract. Invest Ophthalmol Vis Sci. 2004;45(1):77-85.
25. Kampfenkel K, Vanmontagu M, Inze D. Extraction and determination of ascor-bate and dehydroascorbate from plant tissue. AnalBiochem. 1995;225(1): 165-167.
26. Pirie A. Alight-catalysed reaction in the aqueous humor of the eye. Nature. 1965; 205:500-501.
27. Takano S, Ishiwata S, Nakazawa M, Mizugaki M,Tamai M. Determination of ascorbic acid in human vitreous humor by high-performance liquid chromatography with UV detection. Curr Eye Res. 1997;16(6):589-594.
28. Eaton JW. Is the lens canned? Free Radic Biol Med. 1991;11(2):207-213.
29. Buettner GR. In the absence of catalytic metals ascorbate does notautoxidize at pH 7: ascorbate as a test for catalytic metals. JBiochem Biophys Methods. 1988; 16(1):27-40.
30. Yoshida Y, Furuta S, Niki E. Effects of metal chelating agents on the oxidation of lipids induced by copper and iron. Biochim Biophys Acta. 1993;1210(1):81-88.
31. Duarte TL, Lunec J. Review: when is an antioxidant not an antioxidant? a review of novel actions and reactions of vitamin C. Free Radic Res. 2005;39(7):671-686.
32. Rose RC, Richer SP, Bode AM. Ocular oxidants and antioxidant protection. Proc Soc Exp Biol Med. 1998;217(4):397-407.
33. Garland DL. Ascorbic acid and the eye. Am J Clin Nutr. 1991;54(6)(suppl):1198S-1202S.
34. García-Castiñ̃eiras S, Velazquez S, Martí́nez P, Torres N. Aqueous humor hydrogen peroxide analysis with dichlorophenol-indophenol. Exp Eye Res. 1992; 55(1):9-19.
35. 2. Invest Ophthalmol Vis Sci. 1998;39(7):1188-1197.
36. Linster CL, Van Schaftingen E. Vitamin C biosynthesis, recycling and degradation in mammals. FEBS J. 2007;274(1):1-22.
37. Cicik E, Tekin H, Akar S, etal. Interleukin-8, nitric oxide and glutathione status in proliferative vitreoretinopathy and proliferative diabetic retinopathy. Ophthalmic Res. 2003;35(5):251-255.
38. Rittenhouse KD, Peiffer RL Jr, Pollack GM. Assessment of ascorbate ocular disposition in the conscious rabbit: an approach using the microdialysis technique. Curr Eye Res. 2000;20(5):351-360.
39. DiMattio J. A comparative study of ascorbic acid entry into aqueous and vitreous humors of the rat and guinea pig. Invest Ophthalmol Vis Sci. 1989;30(11): 2320-2331.
40. +-dependent L-ascorbic acid transporters. Nature. 1999;399(6731):70-75.
41. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report No. 9 [published correction appears in Arch Ophthalmol. 2008;1 26(9):1251 ]. Arch Ophthalmol. 2001;119(10):1439-1452.
42. Gritz DC, Srinivasan M, Smith SD, et al. The Antioxidants in Prevention of Cataracts Study: effects of antioxidant supplements on cataract progression in South India. Br J Ophthalmol. 2006;90(7):847-851.
43. Davies MB, Austin J, Partridge DA. Vitamin C: Its Chemistry and Biochemistry. Cambridge, England: Royal Society of Chemistry; 1991.
44. Erie JC, Butz JA, Good JA, Erie EA, Burritt MF, Cameron JD. Heavy metal concentrations in human eyes. Am J Ophthalmol. 2005;139(5):888-893.
45. Stefáfnsson E, Novack RL, Hatchell DL. Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci. 1990;31(2):284-289.
46. Quiram PA, LeverenzVR, Baker RM, Dang L, Giblin FJ,Trese MT. Microplasmin-induced posteriorvitreous detachmentaffects vitreous oxygen levels. Retina. 2007; 27(8):1090-1096.
47. Brown DM, Nichols BE, Weingeist TA, Sheffield VC, Kimura AE, Stone EM. Procollagen II gene mutation in Stickler syndrome. Arch Ophthalmol. 1992; 110(11):1589-1593.
48. Kubo E, Kumamoto Y, Tsuzuki S, Akagi Y. Axial length, myopia, and the severity of lens opacity at the time of cataract surgery. Arch Ophthalmol. 2006;124 (11):1586-1590.
49. Wong TY, Klein BE, Klein R, Tomany SC, Lee KE. Refractive errors and incident cataracts: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci. 2001;42(7): 1449-1454.
50. Chen S-N, Lin K-K, ChaoA-N, KuoY-H, Ho J-D. Nuclear sclerotic cataract in young patients in Taiwan. J Cataract Refract Surg. 2003;29(5):983-988.
51. Sawa M, Ohji M, Kusaka S, et al. Nonvitrectomizing vitreous surgery for epireti-nal membrane: long-term follow-up. Ophthalmology. 2005;112(8):1402-1408.